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Abstract 2-Deoxyglucose uptake was enhanced in ts371 
KiMuSV-NRK cells when growing at the permissive temperature 
to allow the expression of a transforming p21 ras protein. This 
change is due to a decrease in the Km by approximately 2.5-fold 
without affecting the F m a x of the transporter. The amount of the 
GLUT1 glucose transporter dit not increase as deduced from 
immunoblot experiments on total membranes. Nevertheless, ras-
transformed GLUT1 displays a higher molecular mass due to an 
increased A'-glycosylation of the protein. Experiments made in 
tunicamycin-treated cells indicates that a higher glycosylation is 
responsible for the increase in 2-deoxyglucose uptake in fas-
transformed cells. 
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1. Introduction 
One of the most characteristic and early recognized bio-
chemical markers of the transformed phenotype is the high 
glucose utilization [1-3]. The facilitated uptake of glucose 
across the plasma membrane of mammalian cells is mediated 
by a family of integral membrane glycoproteins, namely, the 
G L U T transporters [4,5]. Among them, the ubiquitous 
G L U T 1 glucose transporter is responsible for the increased 
glucose transport induced by oncogenes and growth factors. 
In some cases, the mechanism of this activation has been 
attributed to an increase in G L U T 1 m R N A levels. This find-
ing has been described in fibroblasts [6-8] as well as in adipo-
cytes [9] after ras transformation and it appears as a result of 
the transcriptional activation of the gene. Two enhancer ele-
ments have been described to be involved in the response to 
oncogenes and growth factors [10]. However, others have 
found that the higher glucose transport accounted in ras-
transformed 3T3-L1 fibroblasts or adipocytes is not due to 
a higher expression of the gene, but to a translocation of 
G L U T 1 from an intracellular pool to the cell surface [11]. 
The intrinsic activity of G L U T 1 may be also modulated 
through changes in the glycosylation level of the protein 
[12,13] and this seems to be the mechanism by which T G F -
ß induces glucose transport in Swiss 3T3 cells [14]. 
Here we present evidence that changes in G L U T 1 glycosy-
lation can be responsible of the ras oncogene stimulation of 2-
deoxyglucose uptake in K i M u S V - N R K cells. 
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2. Materials and methods 
2.1. Materials 
Tunicamycin was from Boehringer Mannheim. Reagents for cell 
culture were from Gibco. 2-Deoxy-D-[U-14C]glucose was from New 
England Nuclear. The Bb polyclonal antibody against brain GLUT1 
was a gift from Dr. A. Zorzano (Dept. Bioquimica, Universität de 
Barcelona, Spain). All the others chemicals and were purchased from 
Sigma or Boehringer Mannheim. 
2.2. Cell culture 
NRK-44F and ts371 KiMuSV-NRK cells were gently supplied by 
Dr. J. Massagué (Sloan Kettering Cancer Institute, New York). Ki-
MuSV-NRK cells originate from NRK cells which carry the KiMuSV 
with a point mutation in the Ki-ras oncogene (?.s-371 KiMuSV) that 
confers thermolability to the oncogenic protein p21Kl~™', which is 
rapidly degraded at 37°C while it remains stable at the permissive 
temperature of 32°C [15,16]. Thus, when these cells were grown at 
the permissive temperature of 32°C they displayed a transformed 
phenotype with a rounded morphology and high refringency, whereas 
they showed a flat morphology when grown at the non-permissive 
temperature of 37°C. Cells were cultured in a humidified atmosphere 
with 5% C0 2 , in Dulbecco's Modified Eagle Medium (DME) contain-
ing 10% foetal calf serum with 100 IU penicillin/ml and 100 ug/ml 
streptomycin, at 32°C or 37°C. After 5 days in these conditions, cells 
were incubated in a glutamine-free medium (incubation medium: 20 
mM Hepes, pH 7.2, 126 mM NaCl, 15 mM NaHCOa, 3.8 mM KC1, 
0.9 mM Na2HP04 , 0.6 mM KH 2P0 4 , 0.6 mM MgS04 , 0.3 mM 
CaCl2, 6 mM glucose) for 20 h [17]. In these conditions, cells are 
quiescent and the glycolytic flux is low. The cell density was 1.15-
1.30X 105 cells/cm2 with a 80% confluence. In experiments with tuni-
camycin, this agent was added to achieve the desired concentration 
and the controls received the same volume of dimethyl sulfoxide as 
vehicle (0.01% v:v). 
2.3. Determination of 2-deoxyglucose uptake 
The uptake of 2-deoxyglucose was determined essentially as de-
scribed previously [18], using 2-deoxy-D-[U-14C]glucose. This assay is 
based in the fact that 2-deoxyglucose is readily taken up and phos-
phorylated by the cells, but it is not further metabolized. Confluent 
cells (35 mm plaques) were incubated at 37°C for the 5 h previous to 
the assay to eliminate the effects of temperature on cell growth and 
glucose concentration in the medium. After washing 3 times in glu-
cose-free medium, the assay was performed at room temperature in 
the same medium without glucose in the presence of 100 uM 2-deoxy-
D-[U-14C]glucose (0.3 uCi/ml). After incubation, 1 ml of 0.1% SDS 
was added to each plaque and the radioactivity in the extract deter-
mined by liquid scintillation counting. Total uptake was corrected for 
simple diffusion by substracting the amount of label taken up in the 
presence of 20 uM cytochalasin B. 
2.4. Western blot experiments 
Cells were harvested with cold phosphate-buffered saline and cen-
trifuged at 12000Xg for 3 min. Then, cell pellets were solubilized in 
extraction buffer (50 mM Tris-HCl, pH 7.2, 100 mM NaCl, 5 mM 
MgCl2, 1% Triton X-100, 0.1% SDS, 0.5% sodium deoxycholate, 
1 mM PMSF, leupeptin 20 ug/ml) and centrifuged at 1200Xg for 
20 min. Supernatants were subjected to SDS-PAGE. Samples were 
then transferred to a Immobilon-P membrane (Millipore), incubated 
with the Bb antibody and visualized by autoradiography by using 
125I-labeled protein A (Amersham). 
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Fig. 1. 2-Deoxyglucose uptake in NRK (left panel) and KiMuSV-NRK cells (right panel). 2-Deoxyglucose uptake was studied in NRK and Ki-
MuSV-NRK cells grown at 37°C (o) or 32°C (•). Cells were maintained in incubation medium for 20 h at the appropriate temperature, the 
medium was renewed and all cells were incubated at 37°C for 5 h. The assay was performed at room temperature as described in Section 2. 
Values are means ± SEM for three independent experiments performed by triplicate. 
2.5. Digestion with glycosidase 
Solubilized cells were incubated at 37°C for 16 h with 10 U/ml of N-
glycosidase F (Boehringer Mannheim) as described in the commercial 
protocol. Fetuin was used as control of complete digestion. 
2.6. Statistical analysis and presentation of results 
Results are given as means ± SEM for the number of independent 
experiments (i.e. distinct cell culture dishes) specified. Significance of 
differences between treatment was determined by Student's f-test. 
3. Results 
from normal and transformed cells disappeared (Fig. 2). Like-
wise, a 38 kDa well-defined band was observed in normal and 
ras-transformed cells, supporting our hypothesis that differ-
ences in molecular mass were due to changes in the 7V-glyco-
sylation pattern of the molecule. This band correspond to the 
previously described unglycosylated form of GLUT1 [13]. 
In order to verify whether changes in JV-glycosylation were 
responsible for the changes in 2-deoxyglucose uptake in ras-
transformed cells, tunicamycin was used as inhibitor of N-
To investigate the role of glucose transport in ras-mediated 
transformation, 2-deoxyglucose uptake was measured in Ki-
MuSV-NRK cells grown at 37°C or at the permissive temper-
ature of 32°C. Fig. 1 shows a time course assay where an 
increase in the sugar uptake is observed in transformed cells 
compared to non-transformed KiMuSV-NRK cells. The up-
take of 2-deoxyglucose was not modified in the parental NRK 
cells, indicating that growth temperature does not affect the 
uptake. The kinetic parameters of this transport were also 
studied in normal and ras-transformed cells, showing a de-
crease in the Km values (5.13 ±0.77 vs. 2.02 ±0.35 mM, re-
spectively) and no changes in Fm a x values (24.6 ±2.96 vs. 
26.4 ±1.09 nmol/mgXmin, respectively), indicating a higher 
affinity for the substrate in transformed cells. 
When cells were grown at the permissive temperature for 
the maintenance of the transformed phenotype, no apparent 
changes were observed in the amount of GLUT1 in a Western 
blot assay using the polyclonal antibody Bb (Fig. 2). This 
figure shows that an heterogeneous 47-75 kDa broad band 
was detected in cell lysates from non-transformed cells, sim-
ilarly to the results obtained in other cell types [7,14,19]. In 
contrast, when cells were grown previously at the permissive 
temperature of 32°C to achieve the transformed phenotype, 
the molecular mass of GLUT1 was markedly increased to 
about 60-90 kDa. These differences in size are due to changes 
in the pattern of N-glycosylation of GLUT1 since when cell 
lysates were digested with JV-glycosidase F prior to the West-
ern blot, the differences in the molecular mass of GLUT1 
Fig. 2. Immunodetection of GLUT1 from normal and transformed 
KiMuSV-NRK cells. Effect of deglycosylation. Cells lysates from 
KiMuSV-NRK cells grown at 37°C and 32°C were analyzed by 
Western blot using the Bb polyclonal antibody (10 ug protein/lane) 
before (—) and after (+) digestion with 7V-glycosydase F. Molecular 
mass markers are shown in the left (kDa). The positive control (C) 
corresponds to 10 (ig of rat brain extract. 
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Fig. 3. A: Effects of tunicamycin on 2-deoxyglucose uptake in nor-
mal and raw-transformed KiMuSV-NRK cells. KiMuSV-NRK cells 
were grown at 32°C (open bars) or 37°C (hatched bars). Cells were 
maintained in incubation medium for 20 h at the appropriate tem-
perature, the medium was renewed and all cells were incubated at 
37°C in the presence of 25 u.M tunicamycin for the indicated period 
of time. 2-Deoxyglucose uptake assay was performed at room tem-
perature with an incubation time of 3 min as described in Section 2. 
Values are means ± SEM for 3 independent experiments performed 
by triplicate. B: Immunodetection of GLUTl in normal and ras-
transformed KiMuSV-NRK cells treated with tunicamycin. Ki-
MuSV-NRK cells were grown at 32°C or 37°C. Cells were main-
tained in incubation medium for 20 h at the appropriate tempera-
ture, the medium was renewed and all cells were incubated at 37°C 
in the presence of 25 uM tunicamycin for the indicated period of 
time. Cells lysates were analyzed by Western blot using the Bb poly-
clonal antibody (10 [ig protein/lane). Molecular mass markers are 
shown in the left (kDa). 
glycosylation. Fig. 3a shows that treatment of cell cultures 
with 25 uM tunicamycin produced a decrease in the sugar 
uptake in transformed cells in a time-dependent manner, 
reaching similar values that those observed in non-trans-
formed cells after 8 h of incubation with the agent. On the 
other hand, this agent does not have significant effects when 
added to non-transformed cells. A parallel Western blot ex-
periment of GLUTl in tunicamycin treated cells shows that 
this compound does induce a decrease in the molecular mass 
of the transporter in transformed cells, supporting the hypoth-
esis that changes in the level of 7V-glycosylation are responsi-
ble for the increase in 2-deoxyglucose uptake in ras-trans-
formed KiMuSV-NRK cells (Fig. 3b). 
4. Discussion 
Cell transformation is accompanied of changes in many 
cellular functions, perturbing normal cellular growth and their 
control mechanisms. One such alteration is a marked increase 
in glucose consumption, also accounted in mitogen-stimulated 
cells [2,3,20,21]. On the other hand, another characteristic of 
transformed cells is an increase in N-glycosylation of cell sur-
face carbohydrates (also known as the 'Warren phenomenon' 
[22]) and it has been described that specific changes such as an 
increase in ß 1-6 branched oligosaccharides are associated with 
malignancy [23,24]. 
We have found a raise in 2-deoxyglucose uptake in Ki-
MuSV-NRK cells when growing at the permissive tempera-
ture to maintain the ras-transformed phenotype, as compared 
with non-transformed cells. This finding is consistent with 
other published works, since an increase in 2-deoxyglucose 
uptake has been described in different cell types transformed 
by ras oncogenes. Several mechanisms have been described as 
responsible for the increase in sugar uptake, such as a higher 
concentration of GLUTl protein [6-9] or the translocation of 
GLUTl from an intracellular pool to the cell surface [11]. In 
fact, several evidences suggest that the specific cellular system 
may be determinant in the mechanism by which oncogenes 
trigger glucose uptake. Thus, in chicken embryo fibroblasts 
transformed by src, an increase in the number of GLUTl 
molecules due to a lower turnover seems to be responsible 
of this change [20], whereas in src-transformed mouse fibro-
blasts an increase in mRNA expression has been described 
[21]. 
In our system, we have shown that the increase in 2-deoxy-
glucose uptake is not consequence of an increase in the 
amount of GLUTl, but of a change in the iV-glycosylation 
pattern of the transporter, which is evidenced as a shift from a 
broad band of 47-75 kDa in non-transformed KiMuSV-NRK 
cells to a band of 60-90 kDa in their transformed counterpart. 
This is relevant because, although it has been described that 
the TV-glycosylation of whole membrane glycoproteins is in-
creased in ray-transformed cells [25-27], this is the first time 
that ras oncogene has been shown to affect the 7V-glycosyla-
tion state of GLUTl. Oligosaccharides, especially ./V-linked 
chains, contribute to the stability and biological function of 
the molecules [28] and changes have been identified in specific 
proteins, which alter in one way or another their properties. 
Although functions such as recognition and binding many 
times are down-regulated by glycosylation, increased 7V-glyco-
sylation has been also associated with a higher biological ac-
tivity: this is a case, for example, of E-cadherin [29] or the 
odßl integrin receptor [30]. 
Several studies suggest a role for ^-glycosylation of 
GLUTl in glucose transport: a TV-linked carbohydrate addi-
tion occurs at Asn-45 [13,31] but there is discrepancy on how 
this glycosylation affects kinetic parameters. Thus, Haspel and 
coworkers [12] have shown an increase in transport activity 
after depletion of asparagine-linked oligosaccharides, while a 
decrease in the Kmax for glucose uptake has been reported in 
3T3 cells after inhibition of glycosylation with tunicamycin 
[32]. More recently, a loss of transport activity after N-glyca-
nase treatment of GLUTl has been reported [33]. Glycosyla-
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tion-defective mutants show a higher Km and it has been 
postulated a role of glycosylation in maintaining a structure 
of G L U T 1 with high affinity for glucose [13]. Furthermore, 
these mutants are defective in the targeting to the plasma 
membrane and present a shorter half-life than wild-type cells 
[34]. 
In K i M u S V - N R K cells, changes in iV-glycosylation lead to 
a higher affinity for glucose as a result of a decrease in the Km 
without apparent changes in the F m a x . This finding is in agree-
ment with the results reported in tumorigenic human hybrids, 
where a decrease in the Km occurs associated to an increase in 
JV-glycosylation of G L U T 1 [35], in Swiss 3T3 cells treated 
with T G F - ß [14] or in a respiratory-deficient mutan t of the 
V79 hamster fibroblast cell line [36]. In these two cases, an 
increase in glucose transport occurs concomitant to an hyper-
glycosylation of the molecule in the absence of changes in the 
amount of protein. 
In summary, our results support the motion that , together 
with regulation of gene expression and cell localization, 
changes in ^-glycosylation could be a physiological mecha-
nism of glucose transport control. 
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